Surgrx

Redwood City, United States Founded: 2001 • Age: 25 yrs Acquired By Ethicon
Tissue sealing and hemostasis systems are developed for laparoscopic surgery.

About Surgrx

Surgrx is a Healthcare company based in Redwood City (United States) founded in 2001, and was acquired by Ethicon in August 2008. It operates as a tissue sealing and hemostasis systems are developed for laparoscopic surgery. Surgrx has raised $62.5 million across 5 funding rounds from investors including Magnetar Capital, Alta Partners and NEA. The company was acqui-hired. Its focus areas include Life Sciences, Surgical Instruments and Hemostats. Its competitors include Prytime Medical Devices, Biom'Up, Abyrx, LifeBond and Obsidio and 4 more; 8 of its 9 listed competitors have raised funding.

Company details

Surgrx was founded in 2001 in Redwood City, United States, within the medical devices sector. Tissue sealing and hemostasis systems are developed for use in laparoscopic and open surgical procedures. Proprietary Smart Electrode Technology is featured in the EnSeal product to enable hemostasis. Tissues are grasped, dissected, sealed, and transected by the system, with vessel seals provided during operations.

  • Headquarters Redwood City, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website surgrx.com
  • Acquired by Ethicon (Aug 2008)
Key Metrics
  • Total Equity Funding
    $62.5M (USD)

    in 5 rounds

  • Latest Funding Round
    $20M (USD), Series F

    Apr 2007

  • Investors
  • Acquired by
    Ethicon

    (Aug 2008)

Funding Insights of Surgrx

Surgrx has successfully raised a total of $62.5M across 5 strategic funding rounds. The most recent funding activity was a Series F round of $20 million completed in April 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $62.5M
  • Total Rounds 5
  • Last Round Series F β€” $20M
  • First Round $5M

    (Jan 2004)

  • Investors Count 5

All 5 funding rounds of Surgrx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2007$20MSeries F––
Jul 2005$21MSeries E––
Sep 2004$12MSeries D––
Mar 2004$4.5MSeries C––
Jan 2004$5MSeries B––
Valuation history

6 investors in total: 6 institutional.

Investors in Surgrx

Surgrx has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Magnetar Capital, Alta Partners and NEA.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Magnetar Capital is engaged in alternative asset management.
–magnetar.comEvanston, United States
Venture capital firm focused on healthcare companies
–altapartners.comJackson, United States
Venture capital investments are offered to startups by NEA.
–nea.comMenlo Park, United States
-
–ctventures.com-
Investments are made in US life sciences and healthtech firms.
–prospectventures.comPalo Alto, United States
Specializes in surgical sutures and wound closure devices.
1886ethicon.comCincinnati, United States
Premium access

Investor details for Surgrx

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Surgrx

4 dated milestones of Surgrx across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Surgrx is founded.
  2. Funding First funding round of $5.0M.
  3. Funding Latest funding round, Series F, of $20.0M.
  4. Exit Acquired by Ethicon.

Competitors of Surgrx

Surgrx has 9 listed competitors in our database, 8 of them funded. They include Prytime Medical Devices, Biom'Up, Abyrx, LifeBond and Obsidio, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
prytimemedical.com2011Boerne, United States$10M41
Developer of minimally invasive large vessel occludes for hemorrhage control in trauma patients
biomup.com2005Saint Priest Bramefant, France$43.82M–
Hemostatic products for surgical applications are developed using collagen-based materials.
abyrx.com2013Irvington, United States$10M–
Hemostatic bone putty is developed for surgical bone bleeding control.
life-bond.com2007Caesarea, Israel$56.5M–
Absorbable surgical sealants and hemostats are developed for leakage prevention.
obsidiomed.com2018Solana Beach, United States$3M–
Shear-thinning biomaterial is developed to control blood flow minimally invasively.
endomedix.com2005Newark, United States$1.99M–
Hydrogel solutions for surgery and wound care are developed.
archtherapeutics.com2006Natick, United States$320,0008
Hemostasis and sealant technology
novuson.com2014Bothell, United States$2.88M3
Ultrasound devices for tissue ablation and hemostatic control are provided.
z-medica.com2002Wallingford, United States–124
Hemostatic products for bleeding control are provided by Z-Medica.
Premium access

Detailed competitors of Surgrx

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Medical Equipment & Supplies

10 companies that operate in the same segment as Surgrx (Medical Equipment & Supplies), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Software and integrated solutions for surgical and radiotherapy applications
1989Munchen, Bayern, GermanyUSD 5.38 MUSD 1.18 M18
Robotic waterjet system for prostate tissue removal is developed.
2009Redwood City, California, United StatesUSD 348.84 MUSD 308.05 M756
Collaborative surgical robotic systems are provided for hospital procedures.
2014Cambridge, Cambridgeshire, United KingdomUSD 1.68 BUSD 48.75 M680
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.62 M–91
Augmented reality systems for guiding surgical procedures are developed.
2014Yokneam Illit, North District, IsraelUSD 142.6 M––
Manufacturer of imaging and surgical products
1919Tokyo, Tokyo, Japan–USD 6.49 B35,933
Injectable packaging, containment, and delivery solutions are manufactured.
1923Exton, Pennsylvania, United States–USD 3.07 B10,600
Rapid infusion systems are provided for critically ill patients.
2012Durham, North Carolina, United StatesUSD 77.98 M––
Mobile robots are manufactured for industries including healthcare and agriculture.
2013Odense, DenmarkUSD 81.44 M–303
Visualization systems for surgical procedures are developed using machine learning.
2016Seattle, Washington, United StatesUSD 74.25 M–52
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Surgrx

Premium access

Complete news archive for Surgrx

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surgrx

Surgrx was founded in 2001 and raised its 1st funding round 3 years after it was founded.

Surgrx is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.

Surgrx is a funded company, having raised a total of $62.5M across 5 funding rounds to date. The company's 1st funding round was a Series B of $5M, raised on Jan 2004.

Surgrx was founded in 2001 in Redwood City, United States, within the medical devices sector. Tissue sealing and hemostasis systems are developed for use in laparoscopic and open surgical procedures. Proprietary Smart Electrode Technology is featured in the EnSeal product to enable hemostasis. Tissues are grasped, dissected, sealed, and transected by the system, with vessel seals provided during operations.

Surgrx's top competitors include Prytime Medical Devices, Arch Therapeutics and Biom'Up.

Surgrx has 6 investors. Key investors include Magnetar Capital, Alta Partners, NEA, California Technology Ventures, and Prospect Venture Partners.

Yes. Surgrx was acquired by Ethicon in August 2008.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available